2010 No. 1143
The Misuse of Drugs (Designation) (Amendment) (England, Wales and Scotland) Order 2010
Made
Laid before Parliament
Coming into force
The Secretary of State, in exercise of the powers conferred by section 7(4) and (5) of the Misuse of Drugs Act 19711 and after consultation with the Advisory Council on the Misuse of Drugs in accordance with section 7(7) of that Act, hereby makes the following Order:
Citation, commencement, interpretation and extent1
1
This Order may be cited as the Misuse of Drugs (Designation) (Amendment) (England, Wales and Scotland) Order 2010 and shall come into force on 16th April 2010.
2
In this Order “the 2001 Order” means the Misuse of Drugs (Designation) Order 20012.
3
This Order extends to England, Wales and Scotland.
Amendment to the 2001 Order2
In Part 1 of the Schedule to the 2001 Order—
a
in paragraph 1(a), after “methcathinone”, insert—
4–methylmethcathinone
b
after paragraph 1(p), insert—
q
Any compound (not being bupropion, diethylpropion, pyrovalerone or a compound for the time being specified in sub–paragraph (a) above) structurally derived from 2–amino–1–phenyl–1–propanone by modification in any of the following ways, that is to say,
i
by substitution in the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl or halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents;
ii
by substitution at the 3–position with an alkyl substituent;
iii
by substitution at the nitrogen atom with alkyl or dialkyl groups, or by inclusion of the nitrogen atom in a cyclic structure.
(This note is not part of the Order)